In 2024 we earnt royalties, milestone payment (one off) and sales from the PRV (one off). In 2025 we will earn royalties and there is some potential for the one off sales milestone payment for the first commerical sale in the EU but it will be of a smaller value compared to 2024. It is important to note our costs are incredibly low and that we're cash flow positive on royalty income alone. The one off payments make up the majority of our profit(s) and there's still plenty of them to be hit but it's harder to predict when they will land exactly.
- Forums
- ASX - By Stock
- Ann: DAYBUE (trofinetide) 2024 net sales US$348 million
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.28%
!
$12.54

In 2024 we earnt royalties, milestone payment (one off) and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 665 | $12.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.55 | 235 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 13.160 |
2 | 24 | 12.550 |
1 | 400 | 12.540 |
1 | 500 | 12.450 |
1 | 500 | 12.420 |
Price($) | Vol. | No. |
---|---|---|
11.920 | 25 | 2 |
12.170 | 1 | 1 |
12.180 | 12 | 1 |
12.800 | 78 | 1 |
12.830 | 1010 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |